Theoretical studies of HIV-1 reverse transcriptase inhibition.

Area of Science:

• Computational chemistry
• Structural biology
• Drug design

Background:

• Accurate calculation of ligand-protein binding affinity is crucial for rational drug design.
• The human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) is a key target for antiviral therapies.
• Understanding binding mechanisms can guide the development of more effective inhibitors.

Purpose of the Study:

• To theoretically study the binding of five ligands to HIV-1 RT.
• To compare the efficacy of two computational methods: alchemical free energy perturbation (FEP) and pathway methods.
• To identify key interactions for designing improved HIV-1 RT inhibitors.

Main Methods:

• Molecular dynamics (MD) simulations using hybrid QM/MM potentials.
• Alchemical free energy perturbation (FEP) method.
• Pathway method to calculate potential of mean force (PMF).
• Molecular electrostatic potential (MEP) analysis.

Main Results:

• Both FEP and pathway methods can distinguish between potent and less potent HIV-1 RT inhibitors.
• Key interactions involve magnesium cations and specific residues (His539, Asp443, Glu478, Asp498, Asp549).
• Ligand MEPs show better complementarity with the active site for higher binding energies, indicating potential for optimization.

Conclusions:

• Computational methods like FEP and pathway analysis are valuable tools for drug design against HIV-1 RT.
• Optimizing interactions with magnesium-binding residues and His539 is critical for enhancing inhibitory activity.
• Further refinement of ligand design can improve binding affinity and reduce repulsive interactions.